ENPP3 Inhibitor 1, identified by its CAS number 2803505-90-8, is a chemical compound that serves as an inhibitor of the enzyme ecto-nucleotide triphosphate diphosphohydrolase 3 (ENPP3). This enzyme is involved in nucleotide metabolism and plays a role in various biological processes, including the regulation of extracellular nucleotide levels. The inhibition of ENPP3 can have implications in therapeutic areas such as cancer and metabolic disorders, where modulation of nucleotide signaling is crucial. The compound typically exhibits characteristics such as a specific molecular structure that allows it to interact selectively with the target enzyme, potentially leading to altered enzymatic activity. Its pharmacological profile may include properties such as solubility, stability, and bioavailability, which are essential for its effectiveness as a therapeutic agent. Additionally, the compound's safety and toxicity profiles would be evaluated in preclinical and clinical studies to ensure its suitability for potential medical applications.

ENPP3 Inhibitor 1

2803505-90-8: ENPP3 Inhibitor 1, identified by its CAS number 2803505-90-8, is a chemical compound that serves as an inhibitor of the enzyme ecto-nucleotide triphosphate diphosphohydrolase 3 (ENPP3). This enzyme is involved in nucleotide metabolism and plays a role in various biological processes, including the regulation of extracellular nucleotide levels. The inhibition of ENPP3 can have implications in therapeutic areas such as cancer and metabolic disorders, where modulation of nucleotide signaling is crucial. The compound typically exhibits characteristics such as a specific molecular structure that allows it to interact selectively with the target enzyme, potentially leading to altered enzymatic activity. Its pharmacological profile may include properties such as solubility, stability, and bioavailability, which are essential for its effectiveness as a therapeutic agent. Additionally, the compound's safety and toxicity profiles would be evaluated in preclinical and clinical studies to ensure its suitability for potential medical applications.

<p>ENPP3 Inhibitor 1 is a selective inhibitor of ENPP3, exhibiting an IC50 value of 0.15 µM, compared to an IC50 of 41.4 µM for ENPP1. It demonstrates antitumor effects against breast and cervical cancers.</p>

CAS 2803505-90-8

ENPP3 Inhibitor 1

ENPP3 Inhibitor 1

Ref: TM-T203208